Citation Impact
Citing Papers
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Kaempferol and inflammation: From chemistry to medicine
2015
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Heparanase Regulates Secretion, Composition, and Function of Tumor Cell-derived Exosomes
2013
EGFR and cancer prognosis
2001 Standout
Anti-cancer natural products isolated from chinese medicinal herbs
2011 Standout
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Cutting-Edge Apoptosis-Based Therapeutics
2007
The Role of Short-Chain Fatty Acids in Health and Disease
2014 Standout
Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions
2015
The RB and p53 pathways in cancer
2002 Standout
Evidence that fibroblasts derive from epithelium during tissue fibrosis
2002 Standout
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs
2010 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape
2021 StandoutNobel
Natural products: A continuing source of novel drug leads
2013 Standout
Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice
2009
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Type 1 diabetes: role of intestinal microbiome in humans and mice
2011
Intestinal microflora and metabolic diseases
2009
Targeting the p53–MDM2 interaction to treat cancer
2004
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
2019
Dissection of Key Events in Tubular Epithelial to Myofibroblast Transition and Its Implications in Renal Interstitial Fibrosis
2001 Standout
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
2002
Playing the DISC: Turning on TRAIL death receptor-mediated apoptosis in cancer
2009
The gut microbiota and Type 1 Diabetes
2015
Oncogenes as Novel Targets for Cancer Therapy (Part IV)
2005
Curcumin as “Curecumin”: From kitchen to clinic
2007 Standout
Anticancer drugs from nature—natural products as a unique source of new microtubule-stabilizing agents
2007
Lipid-based systemic delivery of siRNA
2009
WNT Signaling in Cardiac and Vascular Disease
2017
Pyrrolidinyl‐Spirooxindole Natural Products as Inspirations for the Development of Potential Therapeutic Agents
2007 Standout
Enterocytes’ tight junctions: From molecules to diseases
2011
Shedding light on the cell biology of extracellular vesicles
2018 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Discovery of curcumin, a component of golden spice, and its miraculous biological activities
2011 Standout
Increased intestinal permeability precedes clinical onset of type 1 diabetes
2006
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Intestinal barrier function: Molecular regulation and disease pathogenesis
2009
Leaking gut in type 1 diabetes
2008
Regulation of intestinal epithelial permeability by tight junctions
2012 Standout
p53—A Natural Cancer Killer: Structural Insights and Therapeutic Concepts
2006
Type 1 diabetes
2013 Standout
The intestinal epithelial barrier: a therapeutic target?
2016 Standout
(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma
2010
The future of antisense therapy: combination with anticancer treatments
2003
Classification of anticancer drugs—a new system based on therapeutic targets
2003
Activation of apoptosis signalling pathways by reactive oxygen species
2016 Standout
Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity
2007
The Chemistry and Biology of Epothilones—The Wheel Keeps Turning
2007
Therapeutic exploitation of the p53 pathway
2002
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Natural compounds for cancer treatment and prevention
2009 Standout
The basics of epithelial-mesenchymal transition
2009 Standout
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
In vitro and in vivo accelertration of the neoplastic phenotype of a low‐tumorigenicity rat bladder carcinoma cell line by transfected transforming growth factor‐α
1994
The p53 pathway: positive and negative feedback loops
2005 Standout
Cytotoxic effect of a fusion protein from transforming growth factora andPseudomonas exotoxin on rat and human bladder carcinoma cells in vitro
1994
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Curcumin: From ancient medicine to current clinical trials
2008 Standout
The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells
2013
Exosomes
2019 Standout
Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
2008
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo
2006
Curcumin, a Dietary Component, Has Anticancer, Chemosensitization, and Radiosensitization Effects by Down-regulating the MDM2 Oncogene through the PI3K/mTOR/ETS2 Pathway
2007
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action
2008
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Melatonin inhibits alcohol-induced increases in duodenal mucosal permeability in rats in vivo
2013
Innate Immune Recognition of Cancer
2015
Pretreatment with Dexamethasone Increases Antitumor Activity of Carboplatin and Gemcitabine in Mice Bearing Human Cancer Xenografts
2004
Spermidine in health and disease
2018 StandoutScience
Butyrate and Type 1 Diabetes Mellitus: Can We Fix the Intestinal Leak?
2010
Vesicles and Liposomes: A Self‐Assembly Principle Beyond Lipids
2003 Standout
Spermidine Prolongs Lifespan and Prevents Liver Fibrosis and Hepatocellular Carcinoma by Activating MAP1S-Mediated Autophagy
2017
p53 – ein natürlicher Krebskiller: Einsichten in die Struktur und Therapiekonzepte
2006
Role of the gastrointestinal ecosystem in the development of type 1 diabetes
2015
Early role of Fsp1 in epithelial-mesenchymal transformation
1997
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Amino Acid Transporters in Cancer and Their Relevance to “Glutamine Addiction”: Novel Targets for the Design of a New Class of Anticancer Drugs
2015
Flavonoids in Cancer and Apoptosis
2018 Standout
Lactobacillus johnsonii inhibits indoleamine 2,3‐dioxygenase and alters tryptophan metabolite levels in BioBreeding rats
2013
Melatonin decreases duodenal epithelial paracellular permeability via a nicotinic receptor–dependent pathway in rats in vivo
2012
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Glycosylation Changes in Brain Cancer
2017
NSAIDs Inhibit Tumorigenesis, but How?
2013
Genistein, a Dietary Isoflavone, Down-Regulates the MDM2 Oncogene at Both Transcriptional and Posttranslational Levels
2005
The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease
2020 Standout
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Li Nan being referenced
Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKL
2010
Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
1992
Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model
2008
Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention
2014
Neonatal Formula Feeding Leads to Immunological Alterations in an Animal Model of Type 1 Diabetes
2008
Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses
2015
Preclinical pharmacology of epothilone D, a novel tubulin-stabilizing antitumor agent
2005
Colon Tumor Cell Growth–Inhibitory Activity of Sulindac Sulfide and Other Nonsteroidal Anti-Inflammatory Drugs Is Associated with Phosphodiesterase 5 Inhibition
2010
A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity
2012
Anti-Tumor Efficacy of a Novel Antisense Anti-MDM2 Mixed-Backbone Oligonucleotide in Human Colon Cancer Models: p53-Dependent and p53-Independent Mechanisms
2002
A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt/mTOR Signaling and Induction of Autophagy
2013
EX VIVO EXPANDED HUMAN Vλ9Vδ2+ λδ-T CELLS MEDIATE INNATE ANTITUMOR ACTIVITY AGAINST HUMAN PROSTATE CANCER CELLS IN VITRO
2005
Changes in Intestinal Morphology and Permeability in the BioBreeding Rat Before the Onset of Type 1 Diabetes
2005
Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms.
2001